TAZloC-Beta 50 Tablet PR

Description

About TAZloC-Beta 50 Tablet PR:
TAZloC-Beta 50 Tablet PR combines Telmisartan and Metoprolol Succinate to provide enhanced blood pressure control.

• Telmisartan (40mg): An angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers vascular resistance.

• Metoprolol Succinate (50mg): A beta-blocker that slows the heart rate and decreases cardiac workload.

This combination is suitable for patients with hypertension who require stronger dual-action therapy and may also reduce cardiovascular risk in patients with heart disease.

How It Works:

• Telmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction.

• Metoprolol Succinate: Reduces heart rate and cardiac output, lowering blood pressure.

• Together, they provide effective dual-action antihypertensive therapy for better blood pressure management and cardiovascular protection.

Uses:

• Management of high blood pressure (hypertension)

• Reduces risk of heart attack, stroke, and heart failure

• Suitable for patients needing combined ARB and beta-blocker therapy

Directions for Use:

• Take once daily, preferably at the same time each day, as prescribed by your doctor.

• Swallow the tablet whole with water, preferably with food.

• Maintain a healthy lifestyle, balanced diet, and regular exercise to optimize blood pressure control.

Side Effects:
Common side effects may include:

• Dizziness or lightheadedness

• Fatigue

• Slow heart rate (bradycardia)

• Mild gastrointestinal discomfort (nausea, diarrhea)

Seek medical attention if you experience severe dizziness, fainting, swelling, irregular heartbeat, or difficulty breathing.

Precautions:

• Avoid in patients with severe liver or kidney disease, asthma, heart block, or hypotension

• Monitor blood pressure, heart rate, and kidney function regularly

• Not recommended during pregnancy or breastfeeding unless prescribed